Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genexol-PM and carboplatin in advanced ovarian cancer
NCT00886717Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- May 2008
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel polymeric micelle in ovarian cancer, sponsored by Asan Medical Center. Primary endpoints: Maximum Tolerated Dose and Recommended Phase II Dose. Status: unknown.
02
Drugs
paclitaxel polymeric micelle
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00886717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886717.